Stock 601607 SHANGHAI PHARMACEUTICALS HOLDING CO., LTD
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Shanghai Pharmaceuticals Holding Co., Ltd

Equities

601607

CNE000000C82

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-07-08 pm EDT 		5-day change 1st Jan Change
19.17 CNY +0.63% Intraday chart for Shanghai Pharmaceuticals Holding Co., Ltd -0.57% +14.58%
Jul. 04 Shanghai Pharmaceuticals Gets Nod to Register Ezetimibe Tablets MT
Jun. 28 Shanghai Pharmaceuticals Holding Co., Ltd Announces Final Dividend for the Year Ended 31 December 2023, Payable on 27 August 2024 CI

Other languages

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Shanghai Pharmaceuticals Gets Nod to Register Ezetimibe Tablets
Shanghai Pharmaceuticals Holding Co., Ltd Announces Final Dividend for the Year Ended 31 December 2023, Payable on 27 August 2024
Shanghai Pharmaceuticals Holding Co., Ltd Announces the Appointment of Zhang Wenxue as Non-Executive Director and Member of the Strategy Committee
Shanghai Pharmaceuticals Holding Co., Ltd Announces Resignation of Chen Fashu as Non-Executive Director
Shanghai Pharma Gets Clinical Trial Approval for Antidepressants
Shanghai Pharmaceuticals' Unit Gets Nod for Raw Drug Material for Hypertension, Heart Disease; Shares Down 3%
Shanghai Pharmaceuticals Unit Gets Green Light to Market Cancer Drug
Shanghai Pharmaceuticals Gets Regulatory Nod to Trial Tumor Drug
Shanghai Pharmaceuticals Holding's Q1 Profit Rises 2% as Revenue Grows 6%
Shanghai Pharmaceuticals Holding Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024
Shanghai Pharma's Profit Plunges 33% in 2023 Despite 12% Revenue Growth; Shanghai Shares Rise 4%
Shanghai Pharmaceuticals Holding Co., Ltd Proposes Final Dividend for the Year Ended 31 December 2023
Shanghai Pharmaceuticals Holding Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023
Shanghai Pharmaceuticals Gets Nod to Register Amiodarone Hydrochloride Injection
Shanghai Pharma Names Chairman; Vice Chairman Resigns
Shanghai Pharmaceuticals Holding Co., Ltd Announces Executive Changes
Shanghai Pharma Unit's Citicoline Sodium Injection Passes Regulatory Evaluation
Shanghai Pharma Receives Approval For New Dosage of Leukemia Drug
Shanghai Pharma, Yunnan Baiyao Renew Sales, Procurement Deal
Shanghai Pharmaceuticals Holding Co., Ltd Announces Change of Joint Company Secretary
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 601607 Stock
  4. News Shanghai Pharmaceuticals Holding Co., Ltd
  5. Other languages